Business / Finance

RSS

lululemon athletica second quarter net revenue increases 39% to $212.3 million

lululemon athletica inc. today announced financial results for the second quarter ended July 31, 2011.

9 Sep 2011

Astex selects PharmaVentures to assist in divesment of CMC & Formulation Facility

PharmaVentures Limited, experts in deals and alliances, are pleased to announce that they have been engaged by leading drug discovery company, Astex Pharmaceuticals to seek a buyer for an established full service CMC & Formulation Facility in Pleasanton, California. The engagement will utilise PharmaVentures' asset divestment expertise in the life sciences sector.

9 Sep 2011

Bristol-Myers Squibb acquires Amira Pharmaceuticals

Bristol-Myers Squibb Company announced today that it has completed its previously announced acquisition of privately held Amira Pharmaceuticals, Inc., a small-molecule pharmaceutical company focused on the discovery and early development of new drugs to treat inflammatory and fibrotic diseases.

9 Sep 2011

Merus Labs International announces first quarter gross profit of $2,075,782

Merus Labs International Inc. today reported its financial results for the quarter ended August 31, 2011.

8 Sep 2011

Maxygen increases stock repurchase program to $20 million

Maxygen, Inc., a biotechnology company, today announced that its Board of Directors has approved an increase to the company's current stock repurchase program from $10.0 million to $20.0 million. The repurchase program expires on December 31, 2011.

8 Sep 2011

MRG reports 6.5% annual growth in the US and European endoscope market through 2015

According to Millennium Research Group (MRG), the global authority on medical technology market intelligence, the overall United States and European endoscope market will show a sustained growth averaging 6.5 percent per year through 2015, primarily driven by strong growth in the large GI endoscope segment, but also seeing notable growth in cameras.

From Evident Corporation - Life Sciences 8 Sep 2011

LabCorp, UnitedHealthcare extend partnership

Laboratory Corporation of America Holdings announced today that it has extended the term of its agreement with UnitedHealthcare Insurance Company, an affiliate of UnitedHealth Group Incorporated for an additional two years. The agreement, which was effective January 1, 2007, will now continue through the end of 2018.

8 Sep 2011

Transcat announces acquisition of Newark's calibration services business

Transcat, Inc., a leading distributor of professional grade handheld test and measurement instruments and accredited provider of calibration, repair and other measurement services, announced today that it has acquired the calibration services business from Newark, a subsidiary of Premier Farnell, PLC, and entered into a strategic alliance whereby Newark will market Transcat's calibration services to its broad customer base of electronic design engineers, maintenance, repair and operations engineers, and industrial buyers.

8 Sep 2011

FTC seeks more details on drug company deal

Pharmacy benefits management company Express Scripts announced in July it was acquiring a similar firm, Medco.

8 Sep 2011

Pharnext puts together €2.5M to fund development of Pleodrug for Charcot-Marie-Tooth disease

Pharnext SAS, a biopharmaceutical company specializing in the development of innovative treatments based on Pleotherapy for severe neurological diseases, today announced that it has put together a €2.5 million round of financing (corresponding to a pre-money company valuation of €60 million).

8 Sep 2011

Pall inaugurates new Singapore Life Sciences Centre of Excellence

Pall Corporation, a global leader in filtration, separation and purification, today inaugurated its Pall Life Sciences Centre of Excellence in Singapore, the latest addition to the company's global customer support network.

From Pall Corporation 8 Sep 2011

Kennet announces $25M investment in WorldOne

Kennet Partners, the technology growth equity investor, has announced a $25 million investment in WorldOne, a market leader in global healthcare data collection. The financing will be used to accelerate WorldOne's global expansion and to fund continued development of new business lines.

8 Sep 2011

Simulations Plus preliminary fourth quarter revenues increase 6.9% to $1.426 million

Simulations Plus, Inc., a leading provider of consulting services and software for pharmaceutical discovery and development, today released preliminary revenues for its fourth fiscal quarter of fiscal year 2011, ended August 31, 2011 (4QFY11), and for the entire fiscal year 2011 (FY11).

7 Sep 2011

Hi-Tech Pharmacal first quarter sales increase 43% to $56.2 million

Hi-Tech Pharmacal Co., Inc. today reported results for the Company's fiscal first quarter ended July 31, 2011.

7 Sep 2011

Continucare fourth quarter total revenue increases 12% to $88.5 million

Continucare Corporation today reported strong financial results for its fourth quarter and fiscal year ended June 30, 2011.

7 Sep 2011

Nasdaq OMX Stockholm approves EpiCept's request for primary listing of common stock

EpiCept Corporation today announced that Nasdaq OMX Stockholm AB has approved the Company's request for a primary listing of its common stock on the Nasdaq OMX Stockholm Exchange.

7 Sep 2011

Golden Meditech launches Taiwan representative office

Golden Meditech Holdings Limited, which embodies a leading medical devices enterprise, a major brand name in haematology hospital and the largest stem cell cord blood banking operator in China, is pleased to announce the launch of its Taiwan representative office today.

6 Sep 2011

NanoLogix to move R&D operations from Cincinnati to its headquarters in Hubbard

NanoLogix, an innovator in the accelerated detection and identification of microorganisms, announced today it will move its research and development operations from Cincinnati to its headquarters in Hubbard, Ohio.

6 Sep 2011

Amakem receives €18m in Series A round of funding

Amakem NV today announced it has raised €18m with a syndicate of leading life sciences investors to advance its ophthalmology drug development portfolio and progress its lead candidate, AMA0076 for glaucoma, to clinical proof of concept.

6 Sep 2011

Sectra reports net sales of SEK 169.3 million for first quarter 2011

IT and medical technology company Sectra's profit after net financial items for the company's first quarter, May - July 2011, rose 25.6% to SEK 16.2 million (12.9), corresponding to a profit margin of 9.6% (7.5). The Group reports an operating profit of SEK 6.5 million (9.0) and net sales of SEK 169.3 million (172.8). Order bookings rose 13.8% to SEK 190.8 million.

6 Sep 2011